Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma

BACKGROUND: Despite aggressive multimodal treatments the overall survival of patients with high-risk neuroblastoma remains poor. The aim of this study was to identify novel combination chemotherapy to improve survival rate in patients with high-risk neuroblastoma. METHODS: We took a synthetic lethal...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Tsang, Patricia S, Cheuk, Adam T, Chen, Qing-Rong, Song, Young K, Badgett, Thomas C, Wei, Jun S, Khan, Javed
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2012
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3364855/
https://ncbi.nlm.nih.gov/pubmed/22436457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-101
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы